Veronica C. Hoad
YOU?
Author Swipe
View article: Blood donation criteria in Australia: Population knowledge, misperceptions, and impact on donation intent
Blood donation criteria in Australia: Population knowledge, misperceptions, and impact on donation intent Open
Introduction Misperceptions about blood donation eligibility can deter individuals from donating. In Australia, misperceptions of one's eligibility status may be exacerbated by recent changes to donor criteria. However, public knowledge of…
View article: Removing upper age restrictions for returning donors and increasing the new donor upper age: Novel adverse event findings using a comprehensive donor vigilance system in Australia
Removing upper age restrictions for returning donors and increasing the new donor upper age: Novel adverse event findings using a comprehensive donor vigilance system in Australia Open
Background and Objectives In July 2019, Australia removed the upper age limit for returning donors (previously 80 years) and increased the upper age for new donors from 70 to 75 years. This study assessed the safety of our new policy for o…
View article: Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic
Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic Open
View article: International Forum on Donor‐ and Recipient‐triggered Lookback for Traditional Transfusion‐transmitted Infections: Responses
International Forum on Donor‐ and Recipient‐triggered Lookback for Traditional Transfusion‐transmitted Infections: Responses Open
View article: International Forum on Donor‐ and Recipient‐triggered Lookback for Traditional Transfusion‐transmitted Infections: Summary
International Forum on Donor‐ and Recipient‐triggered Lookback for Traditional Transfusion‐transmitted Infections: Summary Open
View article: A Cross-Sectional Study of Measles-Specific Antibody Levels in Australian Blood Donors—Implications for Measles Post-Elimination Countries
A Cross-Sectional Study of Measles-Specific Antibody Levels in Australian Blood Donors—Implications for Measles Post-Elimination Countries Open
Passive immunisation with normal human immunoglobulin (NHIG) is recommended as post-exposure prophylaxis (PEP) for higher-risk measles contacts where vaccination is contraindicated. However, the concentration of measles-specific antibodies…
View article: Has the frequency of <scp>ABO RhD</scp> blood groups in Australian blood donors changed as a result of the removal of the variant <scp>Creutzfeldt–Jakob</scp> disease‐based deferral?
Has the frequency of <span>ABO RhD</span> blood groups in Australian blood donors changed as a result of the removal of the variant <span>Creutzfeldt–Jakob</span> disease‐based deferral? Open
Background and Objectives Until 25 July 2022, Australians who had spent more than 6 months in the United Kingdom or territories between 1980 and 1996 were deferred from blood donation due to the risk of variant Creutzfeldt–Jakob disease. R…
View article: The impact of blood donation deferral strategies on the eligibility of men who have sex with men and other sexual risk behavior in Australia
The impact of blood donation deferral strategies on the eligibility of men who have sex with men and other sexual risk behavior in Australia Open
Background In Australia, a man cannot donate blood if he has had sex with another man within the past 3 months. However, this policy has been criticized as being discriminatory as it does not consider lower risk subgroups, and led to calls…
View article: Seroprevalence of Japanese encephalitis virus-specific antibodies in Australia following novel epidemic spread: protocol for a national cross-sectional study
Seroprevalence of Japanese encephalitis virus-specific antibodies in Australia following novel epidemic spread: protocol for a national cross-sectional study Open
Introduction Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that causes encephalitis and other morbidity in Southeast Asia. Since February 2022, geographically dispersed JEV human, animal and vector detections occurred on…
View article: A donor safety evidence literature review of the short‐ and long‐term effects of plasmapheresis
A donor safety evidence literature review of the short‐ and long‐term effects of plasmapheresis Open
Many blood establishments are expanding plasmapheresis collection capacity to achieve increasing plasma for fractionation volume targets, driven by immunoglobulin product demand. Some adverse events occur in both apheresis and whole blood …
View article: Prevalence of blood donation eligibility in Australia: A population survey
Prevalence of blood donation eligibility in Australia: A population survey Open
Background Reliable estimates of the population proportion eligible to donate blood are needed by blood collection agencies to model the likely impact of changes in eligibility criteria and inform targeted population‐level education, recru…
View article: An Outbreak of Japanese Encephalitis Virus in Australia; What Is the Risk to Blood Safety?
An Outbreak of Japanese Encephalitis Virus in Australia; What Is the Risk to Blood Safety? Open
A widespread outbreak of Japanese encephalitis virus (JEV) was detected in mainland Australia in 2022 in a previous non-endemic area. Given JEV is known to be transfusion-transmissible, a rapid blood-safety risk assessment was performed us…
View article: Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review
Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review Open
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human coronavirus first identified in late 2019 and subsequently declared a worldwide pandemic in March 2020. In this review, we provide an o…
View article: International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses Open
Vox SanguinisVolume 116, Issue 10 p. e71-e120 International Forum International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses Arwa Z. Al-Riyami, Arwa Z. Al-Riyami [email protected] orcid.org/0000-0001-8649-0650…
View article: International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary Open
Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory coronavirus 2(SARS-CoV-2), has rapidly spread since its first declaration by the World Health Organization (WHO) as a global pandemic in March 2020 [1]. Until vaccinat…
View article: SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays Open
Serological testing for SARS-CoV-2-specific antibodies provides important research and diagnostic information relating to COVID-19 prevalence, incidence and host immune response. A greater understanding of the relationship between function…
View article: Motivators of and barriers to becoming a COVID‐19 convalescent plasma donor: A survey study
Motivators of and barriers to becoming a COVID‐19 convalescent plasma donor: A survey study Open
Objectives To determine the motivators and barriers to COVID‐19 convalescent plasma donation by those in the United Kingdom who have been diagnosed with or who have had symptoms of SARS‐CoV‐2 (COVID‐19) but who have not donated. Background…
View article: SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants
SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants Open
The SARS-CoV-2 antibody neutralization response and its evasion by emerging viral variants are unknown. Antibody immunoreactivity against SARS-CoV-2 antigens and Spike variants, inhibition of Spike-driven virus-cell fusion, and infectious …
View article: What are Optimal Bacteriological Screening Test Cut-Offs for Pasteurized Donor Human Milk Intended for Feeding Preterm Infants?
What are Optimal Bacteriological Screening Test Cut-Offs for Pasteurized Donor Human Milk Intended for Feeding Preterm Infants? Open
Background Definitive criteria for microbial screening of pasteurized donor human milk are not well established and international recommendations vary. Aims (1) To review pasteurized donor human milk batch discard due to failed microbial s…
View article: SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays
SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays Open
Background Serological testing for SARS-CoV-2 specific antibodies provides important research and diagnostic information relating to COVID-19 prevalence, incidence, and host immune response. A greater understanding of the relationship betw…
View article: Severe acute respiratory syndrome coronavirus‐2: implications for blood safety and sufficiency
Severe acute respiratory syndrome coronavirus‐2: implications for blood safety and sufficiency Open
Background and Objective Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is a novel coronavirus, first identified in China at the end of 2019 and has now caused a worldwide pandemic. In this review, we provide an overview of t…
View article: Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events
Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events Open
Background and Objectives In 2018, Australian Red Cross Lifeblood changed its plasmapheresis eligibility criteria to allow donors to donate plasma without the requirement of a prior successful whole blood donation. This study evaluated the…
View article: Development and evaluation of formal guidelines for donor selection for human milk banks
Development and evaluation of formal guidelines for donor selection for human milk banks Open
Aim Donor selection for milk banks is essential to ensure the safety and nutritional quality of the donor milk, and to ensure that the prospective donor and her breastfeeding infant do not come to harm through donating. Australian Red Cros…
View article: Blood donation amongst people who inject drugs in Australia: research supporting policy change
Blood donation amongst people who inject drugs in Australia: research supporting policy change Open
Background and objectives Until recently, people in Australia with a history of injection drug use (IDU) were deferred indefinitely from donating blood. Knowledge gaps regarding policy non‐compliance and the prevalence of blood donation pr…
View article: Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type 1 Transmission
Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type 1 Transmission Open
To the Editor: I welcome the findings of Mehand et al. in putting together a methodology that can prioritize emerging infectious diseases in need of research and development (1).These approaches are vital in establishing how global researc…
View article: Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. “Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country” [Transfus Med Hemother. 2019 Apr;46(2):104–10]
Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. “Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country” [Transfus Med Hemother. 2019 Apr;46(2):104–10] Open
View article: Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia
Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia Open
View article: False positive viral marker results in blood donors and their unintended consequences
False positive viral marker results in blood donors and their unintended consequences Open
False positive (FP) viral marker results in blood donors continue to pose many challenges. Informing donors of FP results and subsequent deferral can result in stress and anxiety for donors and additional complexity and workload for blood …
View article: <scp>R</scp>oss<scp>R</scp>iver virus in<scp>A</scp>ustralian blood donors: possible implications for blood transfusion safety
<span>R</span>oss<span>R</span>iver virus in<span>A</span>ustralian blood donors: possible implications for blood transfusion safety Open
BACKGROUND Emerging transfusion‐transmissible pathogens, including arboviruses such as West Nile, Zika, dengue, and Ross River viruses, are potential threats to transfusion safety. The most prevalent arbovirus in humans in Australia is Ros…
View article: Emerging infectious disease outbreaks: estimating disease risk in Australian blood donors travelling overseas
Emerging infectious disease outbreaks: estimating disease risk in Australian blood donors travelling overseas Open
Background and Objectives International travel assists spread of infectious pathogens. Australians regularly travel to South‐eastern Asia and the isles of the South Pacific, where they may become infected with infectious agents, such as de…